These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 35356785)

  • 1. An Update on African Trypanocide Pharmaceutics and Resistance.
    Kasozi KI; MacLeod ET; Ntulume I; Welburn SC
    Front Vet Sci; 2022; 9():828111. PubMed ID: 35356785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic Review and Meta-Analysis on Human African Trypanocide Resistance.
    Kasozi KI; MacLeod ET; Welburn SC
    Pathogens; 2022 Sep; 11(10):. PubMed ID: 36297157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentamidine movement across the murine blood-brain and blood-cerebrospinal fluid barriers: effect of trypanosome infection, combination therapy, P-glycoprotein, and multidrug resistance-associated protein.
    Sanderson L; Dogruel M; Rodgers J; De Koning HP; Thomas SA
    J Pharmacol Exp Ther; 2009 Jun; 329(3):967-77. PubMed ID: 19261919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial.
    Mesu VKBK; Kalonji WM; Bardonneau C; Mordt OV; Blesson S; Simon F; Delhomme S; Bernhard S; Kuziena W; Lubaki JF; Vuvu SL; Ngima PN; Mbembo HM; Ilunga M; Bonama AK; Heradi JA; Solomo JLL; Mandula G; Badibabi LK; Dama FR; Lukula PK; Tete DN; Lumbala C; Scherrer B; Strub-Wourgaft N; Tarral A
    Lancet; 2018 Jan; 391(10116):144-154. PubMed ID: 29113731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug resistance in human African trypanosomiasis.
    Barrett MP; Vincent IM; Burchmore RJ; Kazibwe AJ; Matovu E
    Future Microbiol; 2011 Sep; 6(9):1037-47. PubMed ID: 21958143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo and in vitro sensitivity of Trypanosoma evansi and T. equiperdum to diminazene, suramin, MelCy, quinapyramine and isometamidium.
    Zhang ZQ; Giroud C; Baltz T
    Acta Trop; 1991 Dec; 50(2):101-10. PubMed ID: 1685865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aquaporin 2 mutations in Trypanosoma brucei gambiense field isolates correlate with decreased susceptibility to pentamidine and melarsoprol.
    Graf FE; Ludin P; Wenzler T; Kaiser M; Brun R; Pyana PP; Büscher P; de Koning HP; Horn D; Mäser P
    PLoS Negl Trop Dis; 2013; 7(10):e2475. PubMed ID: 24130910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. African animal trypanocide resistance: A systematic review and meta-analysis.
    Kasozi KI; MacLeod ET; Welburn SC
    Front Vet Sci; 2022; 9():950248. PubMed ID: 36686196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trypanocide Use and Molecular Characterization of Trypanosomes Resistant to Diminazene Aceturate in Cattle in Northern Côte D'Ivoire.
    Ekra JY; Mafie EM; Sonan H; Kanh M; Gragnon BG; N'Goran EK; Srinivasan J
    Trop Med Infect Dis; 2024 Aug; 9(9):. PubMed ID: 39330881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent progress in diagnosis and treatment of Human African Trypanosomiasis has made the elimination of this disease a realistic target by 2030.
    Álvarez-Rodríguez A; Jin BK; Radwanska M; Magez S
    Front Med (Lausanne); 2022; 9():1037094. PubMed ID: 36405602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy for second-stage human African trypanosomiasis.
    Lutje V; Seixas J; Kennedy A
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD006201. PubMed ID: 23807762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Toxicity of Fexinidazole and Nifurtimox Plus Eflornithine in the Treatment of African Trypanosomiasis: A Systematic Review.
    Hidalgo J; Ortiz JF; Fabara SP; Eissa-Garcés A; Reddy D; Collins KD; Tirupathi R
    Cureus; 2021 Aug; 13(8):e16881. PubMed ID: 34513456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial.
    Priotto G; Kasparian S; Mutombo W; Ngouama D; Ghorashian S; Arnold U; Ghabri S; Baudin E; Buard V; Kazadi-Kyanza S; Ilunga M; Mutangala W; Pohlig G; Schmid C; Karunakara U; Torreele E; Kande V
    Lancet; 2009 Jul; 374(9683):56-64. PubMed ID: 19559476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the impact of targeting livestock for the prevention of human and animal trypanosomiasis, at village level, in districts newly affected with T. b. rhodesiense in Uganda.
    Hamill L; Picozzi K; Fyfe J; von Wissmann B; Wastling S; Wardrop N; Selby R; Acup CA; Bardosh KL; Muhanguzi D; Kabasa JD; Waiswa C; Welburn SC
    Infect Dis Poverty; 2017 Feb; 6(1):16. PubMed ID: 28162093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy for second-stage Human African trypanosomiasis.
    Lutje V; Seixas J; Kennedy A
    Cochrane Database Syst Rev; 2010 Aug; (8):CD006201. PubMed ID: 20687080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in Transporters Rather than Drug Targets Are the Principal Determinants of the Different Innate Sensitivities of
    Ungogo MA; Campagnaro GD; Alghamdi AH; Natto MJ; de Koning HP
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA-interference silencing of the adenosine transporter-1 gene in Trypanosoma evansi confers resistance to diminazene aceturate.
    Witola WH; Inoue N; Ohashi K; Onuma M
    Exp Parasitol; 2004; 107(1-2):47-57. PubMed ID: 15208037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular identification of diminazene aceturate-resistant strains of Trypanosoma congolense in naturally infected domestic animals of Yoko in the centre region of Cameroon.
    Mewamba EM; Farikou O; Kamga RMN; Magang MEK; Tume C; Tiofack AAZ; Ravel S; Simo G
    Vet Parasitol Reg Stud Reports; 2020 Apr; 20():100405. PubMed ID: 32448545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced Mitochondrial Membrane Potential Is a Late Adaptation of Trypanosoma brucei brucei to Isometamidium Preceded by Mutations in the γ Subunit of the F1Fo-ATPase.
    Eze AA; Gould MK; Munday JC; Tagoe DN; Stelmanis V; Schnaufer A; De Koning HP
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004791. PubMed ID: 27518185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of arsenical and diamidine uptake and resistance in Trypanosoma brucei.
    Matovu E; Stewart ML; Geiser F; Brun R; Mäser P; Wallace LJ; Burchmore RJ; Enyaru JC; Barrett MP; Kaminsky R; Seebeck T; de Koning HP
    Eukaryot Cell; 2003 Oct; 2(5):1003-8. PubMed ID: 14555482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.